TMEM233 - transmembrane protein 233 Gene
Also Known as DSPB2; IFITMD2
Species: Homo sapiens
Gene Type: protein coding
Gene ID: 387890
About TMEM233
Cytogenetic location: 12q24.23
Genomic coordinates (GRCh38): 12:119,593,774-119,654,295 (from NCBI)
This gene has 2 transcripts (splice variants), 201 orthologues and 4 paralogues. Biased expression in thyroid (RPKM 3.9), brain (RPKM 1.9) and 1 other tissue.
Summary
Predicted to be integral component of membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM233 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001136534.3 | NP_001130006.1 | transmembrane protein 233 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
37117223 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
37117223 | GOA |
EXP: Inferred from Experiment
IDA: Inferred from direct assay
IPI: Inferred from physical interaction
IMP: Inferred from mutant phenotype
IGI: Inferred from genetic interaction
IEP: Inferred from expression pattern
TMEM233 Protein Structure
CD225
CD225: Interferon-induced transmembrane protein (29 - 99)
- 0
- 100
- 109 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
transmembrane protein 233 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Osteogenesis Imperfecta, Type V |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS14704 | TMEM233 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service